CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Trial With Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin (PLD) and Carboplatin in Malignant Gynecologic Tumour's

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00189410
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:03.329189+00:00
Published At: 2010-07-20T00:00:00+00:00
Record Updated At: 2010-07-20
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cancer of the Ovary Treated as 2nd Line Therapy", "Muellerian Mixed Tumours", "Tumours of the Uterus", "Cervical Cancers", "Non-Epithelial Ovarian Tumours"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2010-07-20"
protocolSection.identificationModule.nctId: "NCT00189410"
protocolSection.identificationModule.officialTitle: "Phase II Trial With Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin (PLD) and Carboplatin in Malignant Gynecologic Tumour\u0027s"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.